Western Drug Recalls Cantharidin 0.7% Solution Due to Sterility Concerns
Western Drug is recalling Cantharidin 0.7% Solution because the product lacks assurance of sterility. The recall covers all lots distributed nationwide.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II, and the rubric specifies that FDA Class II recalls with potential for significant injury or hospitalization (implied by sterility failure in a medical product) fall under the Severe category, or at minimum, the rule 'If the agency's own classification is FDA Class I or USDA Class I, never go below 4' suggests a high baseline, but specifically Class II with sterility issues often warrants a 4 due to the risk of serious infection.
Plain-English summary
Western Drug Inc. is recalling Cantharidin 0.7% Solution, a prescription medication, due to a lack of assurance of sterility. The recall includes all lots of the product.
The affected product was distributed nationwide in the United States, specifically in Arizona, California, Georgia, New Mexico, South Carolina, South Dakota, Texas, and Utah. The recall is classified as Class II by the FDA.
Consumers and healthcare providers should stop using the recalled product and contact their healthcare provider for further instructions. The recall is being conducted to ensure patient safety regarding the sterility of the medication.
The recalled product
- Product
- Cantharidin 0.7% Sol, Rx, Western Drug Inc. 106 E. Main Street, Springerville, Arizona 85938
- Manufacturer
- Western Drug
- Category
- Drug — Prescription Medication
- Hazard
- Affected units
- 1
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- all lots
Distribution
Part of a larger recall action
This product is one of 91 recalled by Western Drug under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 91 products in this recall →Related recalls
Same manufacturer · Western Drug
See all →- SevereWestern Drug Recalls Sodium Hydroxide 10% Injection Due to Sterility Concerns
FDA (Drugs) · 2015-12-09
- SevereWestern Drug Recalls Methylcobalamin Injection Due to Sterility Concerns
FDA (Drugs) · 2015-12-09
- SevereWestern Drug Recalls Benadryl Injection Due to Sterility Concerns
FDA (Drugs) · 2015-12-09
- SevereWestern Drug Recalls PZI 40 Insulin Due to Sterility Concerns
FDA (Drugs) · 2015-12-09
- SevereWestern Drug Recalls Ketorolac Injection Due to Sterility Concerns
FDA (Drugs) · 2015-12-09
Same hazard · sterility failure
See all →- SevereAvKare Carboxymethylcellulose Sodium Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2026-09-30
- SevereAvKare Carboxymethylcellulose Sodium Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2026-09-30
- SevereROHTO DIGI-EYE Eye Drops Recalled Over Sterility Assurance Gap
FDA (Drugs) · 2026-07-29
- HighROHTO DRY-AID Eye Drops Recalled Due to Sterility Concerns
FDA (Drugs) · 2026-07-29
- SevereOne-Piece Introducer Tray kits recalled for sterility failure
FDA (Devices) · 2026-07-22
Similar recalls
- SevereSynergy Rx Recalls Cantharidin and Podophyllum Solutions Due to Sterility Concerns
FDA (Drugs) · 2017-03-22
- SevereCantrell Drug Recalls Sodium Bicarbonate Injection Due to Sterility Concerns
FDA (Drugs) · 2017-08-16
- SevereCantrell Drug Company Recalls Calcium Chloride Bags Due to Sterility Concerns
FDA (Drugs) · 2016-12-21
- SevereSodium Hydroxide Solution Recalled Due to Sterility Concerns
FDA (Drugs) · 2014-01-22
- SevereCantrell Recalls Neostigmine Methylsulfate Injection Due to Sterility Concerns
FDA (Drugs) · 2017-08-16
- ModerateSynergy Rx Recalls Retinoic Acid Solution Due to Sterility Concerns
FDA (Drugs) · 2017-03-22